Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study.

Gosche KM, Mortimer JA, Smith CD, Markesbery WR, Snowdon DA.

Neurology. 2002 May 28;58(10):1476-82.

PMID:
12034782
2.

Delayed recall, hippocampal volume and Alzheimer neuropathology: findings from the Nun Study.

Mortimer JA, Gosche KM, Riley KP, Markesbery WR, Snowdon DA.

Neurology. 2004 Feb 10;62(3):428-32.

PMID:
14872025
3.

Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.

den Heijer T, Geerlings MI, Hoebeek FE, Hofman A, Koudstaal PJ, Breteler MM.

Arch Gen Psychiatry. 2006 Jan;63(1):57-62.

PMID:
16389197
4.

Subjective cognitive failures and hippocampal volume in elderly with white matter lesions.

van Norden AG, Fick WF, de Laat KF, van Uden IW, van Oudheusden LJ, Tendolkar I, Zwiers MP, de Leeuw FE.

Neurology. 2008 Oct 7;71(15):1152-9. doi: 10.1212/01.wnl.0000327564.44819.49.

PMID:
18838662
5.

MRI measures of entorhinal cortex vs hippocampus in preclinical AD.

Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert MS.

Neurology. 2002 Apr 23;58(8):1188-96.

PMID:
11971085
6.

Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease.

Sze CI, Troncoso JC, Kawas C, Mouton P, Price DL, Martin LJ.

J Neuropathol Exp Neurol. 1997 Aug;56(8):933-44.

PMID:
9258263
7.

MRI and CSF studies in the early diagnosis of Alzheimer's disease.

de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.

J Intern Med. 2004 Sep;256(3):205-23.

8.

Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.

Tam CW, Burton EJ, McKeith IG, Burn DJ, O'Brien JT.

Neurology. 2005 Mar 8;64(5):861-5.

PMID:
15753423
9.
10.

Neuropathology of older persons without cognitive impairment from two community-based studies.

Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS.

Neurology. 2006 Jun 27;66(12):1837-44.

PMID:
16801647
11.

Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology.

Ikonomovic MD, Mufson EJ, Wuu J, Cochran EJ, Bennett DA, DeKosky ST.

J Alzheimers Dis. 2003 Feb;5(1):39-48.

PMID:
12590165
12.

Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

Riley KP, Snowdon DA, Markesbery WR.

Ann Neurol. 2002 May;51(5):567-77.

PMID:
12112102
13.

Peripheral insulin and brain structure in early Alzheimer disease.

Burns JM, Donnelly JE, Anderson HS, Mayo MS, Spencer-Gardner L, Thomas G, Cronk BB, Haddad Z, Klima D, Hansen D, Brooks WM.

Neurology. 2007 Sep 11;69(11):1094-104.

PMID:
17846409
14.

Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial.

Grundman M, Sencakova D, Jack CR Jr, Petersen RC, Kim HT, Schultz A, Weiner MF, DeCarli C, DeKosky ST, van Dyck C, Thomas RG, Thal LJ; Alzheimer's Disease Cooperative Study..

J Mol Neurosci. 2002 Aug-Oct;19(1-2):23-7.

PMID:
12212787
15.

Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.

Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM.

Arch Neurol. 2006 May;63(5):693-9. Erratum in: Arch Neurol. 2007 Sep;64(9):1360-1.

PMID:
16682538
16.

Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years.

Tierney MC, Yao C, Kiss A, McDowell I.

Neurology. 2005 Jun 14;64(11):1853-9.

PMID:
15955933
17.

Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects.

Csernansky JG, Hamstra J, Wang L, McKeel D, Price JL, Gado M, Morris JC.

Alzheimer Dis Assoc Disord. 2004 Oct-Dec;18(4):190-5.

PMID:
15592129
18.

White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.

Burns JM, Church JA, Johnson DK, Xiong C, Marcus D, Fotenos AF, Snyder AZ, Morris JC, Buckner RL.

Arch Neurol. 2005 Dec;62(12):1870-6.

PMID:
16344345
19.

Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.

Galvin JE, Powlishta KK, Wilkins K, McKeel DW Jr, Xiong C, Grant E, Storandt M, Morris JC.

Arch Neurol. 2005 May;62(5):758-65.

PMID:
15883263
20.

Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.

Jicha GA, Parisi JE, Dickson DW, Johnson K, Cha R, Ivnik RJ, Tangalos EG, Boeve BF, Knopman DS, Braak H, Petersen RC.

Arch Neurol. 2006 May;63(5):674-81.

PMID:
16682537

Supplemental Content

Support Center